Complaint filed in Bihar court against Baba Ramdev over Covid-19 medicine claim - Hindustan Times
close_game
close_game

Complaint filed in Bihar court against Baba Ramdev over Covid-19 medicine claim

Muzaffarpur | ByPress Trust of India| Posted by: Jasra Afreen
Jun 24, 2020 05:16 PM IST

The complainant submitted that the Ayush Ministry has asked Patanjali Ayurved to stop advertising and publicising its claims about the medicine.The Ayush Ministry has said that they have not been provided any information with regard to the details of the composition of the ayurvedic medicine, Hashmi said.

A criminal complaint has been filed in a Bihar court against yoga guru Ramdev and Patanjali Ayurved MD Acharya Balkrishna, alleging that they have misled and put at risk the lives of lakhs of people by claiming to have developed a medicine to treat Covid-19.

The complainant has sought registration of a case under IPC sections 420 (cheating and dishonesty inducing delivery of property), 120B (criminal conspiracy) and 270 (malignant act likely to spread infection of disease dangerous to life), among others.(PTI)
The complainant has sought registration of a case under IPC sections 420 (cheating and dishonesty inducing delivery of property), 120B (criminal conspiracy) and 270 (malignant act likely to spread infection of disease dangerous to life), among others.(PTI)

The complaint seeking registration of an FIR on cheating, criminal conspiracy and other charges was filed in the court of Chief Judicial Magistrate Mukesh Kumar here on Tuesday by Tamanna Hashmi, who identifies himself as a social worker and is often in news for his numerous court complaints against politicians over various issues.

HT launches Crick-it, a one stop destination to catch Cricket, anytime, anywhere. Explore now!

The court posted the matter for hearing on June 30.The complainant has named Ramdev, the convenor of the Patanjali Research Institute, and his aide Balkrishna, the organisation’s chairman, as accused.Hashmi submitted that Ramdev and Balkrishna claimed to have prepared “Coronil tablet” to cure Covid-19, which is nothing but misleading.

The complainant submitted that the Ayush Ministry has asked Patanjali Ayurved to stop advertising and publicising its claims about the medicine.The Ayush Ministry has said that they have not been provided any information with regard to the details of the composition of the ayurvedic medicine, Hashmi said.

The complainant has sought registration of a case under IPC sections 420 (cheating and dishonesty inducing delivery of property), 120B (criminal conspiracy) and 270 (malignant act likely to spread infection of disease dangerous to life), among others.

Ramdev’s herbal medicine company Patanjali Ayurved has launched ‘Coronil tablet and Swasari vati’ medicines claiming they can cure the highly contagious disease within seven days.It has also claimed that the two Ayurveda-based medicines have shown 100 per cent favourable results during clinical trials on Covid-19 infected patients except those on a life support system. However, the AYUSH ministry said that the facts of the claim and details of the stated scientific study are not known to it.

It has sought from the company a detailed report on composition, testing and other data of the drugs. The ministry also used powers under a 1954 law to ask the firm to “stop advertising/publicizing” claims of corona cure drug until the issue is examined by it.

A government notification bars companies from advertising a cure without government approval. But it wasn’t immediately clear if the drug can still be sold.

Ramdev said the medicines have been developed by Patanjali Research Center, Haridwar and privately-owned National Institute of Medical Science, Jaipur following all protocols with clinically controlled trial-based evidence. Patanjali group has an estimated turnover of around Rs 10,500 crore.

SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, April 18, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On